Literature DB >> 9294925

Group B coxsackie disease in children.

J F Modlin1, H A Rotbart.   

Abstract

Entities:  

Mesh：

Year:  1997        PMID： 9294925     DOI： 10.1007/978-3-642-60687-8_4

Source DB:  PubMed          Journal:  Curr Top Microbiol Immunol        ISSN： 0070-217X            Impact factor:   4.291


× No keyword cloud information.
  21 in total

1.  Rotavirus and coxsackievirus infection activated different profiles of toll-like receptors and chemokines in intestinal epithelial cells.

Authors:  Jin Xu; Y Yang; C Wang; B Jiang
Journal:  Inflamm Res       Date:  2009-03-19       Impact factor: 4.575

2.  A genetically engineered attenuated coxsackievirus B3 strain protects mice against lethal infection.

Authors:  M Dan; J K Chantler
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

3.  Neonate with coxsackie B1 infection, cardiomyopathy and arrhythmias.

Authors:  Jimmy C Lu; Kelly W Koay; Christian B Ramers; Angelo S Milazzo
Journal:  J Natl Med Assoc       Date:  2005-07       Impact factor: 1.798

4.  In-utero coxsackievirus B4 infection of the mouse thymus.

Authors:  H Jaïdane; A Halouani; H Jmii; F Elmastour; S Abdelkefi; G Bodart; H Michaux; T Chakroun; F Sane; M Mokni; V Geenen; D Hober; M Aouni
Journal:  Clin Exp Immunol       Date:  2016-11-29       Impact factor: 4.330

Review 5.  Type B coxsackieviruses and their interactions with the innate and adaptive immune systems.

Authors:  Christopher C Kemball; Mehrdad Alirezaei; J Lindsay Whitton
Journal:  Future Microbiol       Date:  2010-09       Impact factor: 3.165

6.  Wild-type coxsackievirus infection dramatically alters the abundance, heterogeneity, and immunostimulatory capacity of conventional dendritic cells in vivo.

Authors:  Christopher C Kemball; Claudia T Flynn; Martin P Hosking; Jason Botten; J Lindsay Whitton
Journal:  Virology       Date:  2012-05-01       Impact factor: 3.616

7.  Effects of the Sabin-like mutations in domain V of the internal ribosome entry segment on translational efficiency of the Coxsackievirus B3.

Authors:  Manel Ben M'hadheb-Gharbi; Jawhar Gharbi; Sylvie Paulous; Michèle Brocard; Anastasia Komaromva; Mahjoub Aouni; Katherine M Kean
Journal:  Mol Genet Genomics       Date:  2006-08-15       Impact factor: 3.291

8.  Interspecies differences in virus uptake versus cardiac function of the coxsackievirus and adenovirus receptor.

Authors:  Fabian Freiberg; Martina Sauter; Sandra Pinkert; Thirupugal Govindarajan; Joanna Kaldrack; Meghna Thakkar; Henry Fechner; Karin Klingel; Michael Gotthardt
Journal:  J Virol       Date:  2014-04-16       Impact factor: 5.103

9.  Coxsackievirus replication and the cell cycle: a potential regulatory mechanism for viral persistence/latency.

Authors:  Ralph Feuer; Ignacio Mena; Robb R Pagarigan; Daniel E Hassett; J Lindsay Whitton
Journal:  Med Microbiol Immunol       Date:  2003-08-19       Impact factor: 3.402

10.  Coxsackievirus B3 inhibits antigen presentation in vivo, exerting a profound and selective effect on the MHC class I pathway.

Authors:  Christopher C Kemball; Stephanie Harkins; Jason K Whitmire; Claudia T Flynn; Ralph Feuer; J Lindsay Whitton
Journal:  PLoS Pathog       Date:  2009-10-16       Impact factor: 6.823
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.